PROTALIX BIOTHERAPEUTICS INC's ticker is and the CUSIP is 74365AAB7. A total of 12 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,953,000 | -1.3% | 6,977,000 | 0.0% | 0.07% | -2.6% |
| Q2 2016 | $5,019,000 | +3.4% | 6,977,000 | 0.0% | 0.08% | -44.9% |
| Q1 2016 | $4,853,000 | -3.1% | 6,977,000 | 0.0% | 0.14% | +27.8% |
| Q4 2015 | $5,008,000 | +1.3% | 6,977,000 | 0.0% | 0.11% | -7.7% |
| Q3 2015 | $4,944,000 | -9.6% | 6,977,000 | 0.0% | 0.12% | -5.6% |
| Q2 2015 | $5,471,000 | +5.7% | 6,977,000 | +1.1% | 0.12% | +20.4% |
| Q1 2015 | $5,174,000 | -4.9% | 6,900,000 | 0.0% | 0.10% | -2.8% |
| Q4 2014 | $5,442,000 | – | 6,900,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 4,000,000 | $2,698,000 | 2.68% |
| Opaleye Management Inc. | 3,640,000 | $4,295,000 | 2.11% |
| Mohican Financial Management, LLC | 2,600,000 | $1,851,000 | 1.41% |
| Camber Capital Management LP | 9,000,000 | $6,182,000 | 0.53% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 18,872,000 | $13,435,000 | 0.21% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 10,000,000 | $7,430,000,000 | 0.15% |
| ANGELO GORDON & CO., L.P. | 2,500,000 | $1,780,000 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 6,977,000 | $4,944,000 | 0.12% |
| Baker Brothers Advisors | 3,423,000 | $2,450,000 | 0.02% |
| FEDERATED HERMES, INC. | 5,330,000 | $3,631,000 | 0.01% |